Videos and webinars
-
Innovations In Sterile Connectors Transform CGT Bioprocessing
4/21/2025
Explore advancements in single-use sterile connectors transforming CGT bioprocessing by enhancing fluid handling, reducing contamination, and improving process reliability for next-gen therapies.
-
Emerging Manufacturing Technologies For Cell Therapies | Audience Q&A
4/15/2025
Cell & Gene Live’s Audience Q&A always draws valuable questions in real time from our audience. Rohit Ingale, Head of Manufacturing & MSAT, Arcellx and David O’Donnell, Vice President, Head of Manufacturing, Vor Bio provide detailed responses to audience questions that addressed the importance of vein-to-vein time for non-cancer indications, such as autoimmune diseases.
-
The Impact Of Cell Therapy Manufacturing On Patient Access And Experience
4/15/2025
During this segment of Cell & Gene Live, expert panelists, Rohit Ingale, Head of Manufacturing & MSAT, Arcellx and David O’Donnell, Vice President, Head of Manufacturing, Vor Bio share why improvements in cell therapy manufacturing directly impact the patient experience.
-
Implementing Emerging Manufacturing Technologies For Cell Therapies
4/15/2025
In this segment of Cell & Gene Live, Rohit Ingale, Head of Manufacturing & MSAT, Arcellx and David O’Donnell, Vice President, Head of Manufacturing, Vor Bio emphasize the importance of focusing on solving the problem at hand when adopting new technologies.
-
Emerging Technologies In Cell Therapy Manufacturing: Embracing Automation, Robotics, And AI
4/15/2025
In this segment of our Cell & Gene Live, expert panelists Rohit Ingale, Head of Manufacturing & MSAT, Arcellx and David O’Donnell, Vice President, Head of Manufacturing, Vor Bio define innovation as benefiting patients and emphasize automation and robotics as central to the cause.
-
Cell Therapy's Current Manufacturing Challenges
4/15/2025
In this segment, Cell & Gene’s Chief Editor, Erin Harris, welcomes the audience and introduces the expert panelists, Rohit Ingale, Head of Manufacturing & MSAT, Arcellx and David O’Donnell, Vice President, Head of Manufacturing, Vor Bio.
-
MicroCNX Nano Series Connectors Assembly Overview
2/28/2025
Maintaining sterility is crucial, even in uncontrolled spaces. Learn how this innovative, miniature connector allows you to establish aseptic connections for 1/16" and 1/8" tubing, anywhere you need them.
-
MicroCNX® Series Connectors: Introducing The MicroCNX ULT And MicroCNX Luer
9/23/2024
Experience the future of connectivity. Designed for enhanced simplicity and productivity, these innovative connectors are perfect for cell therapies requiring cryogenic freezing and sterile connections.
-
Point-Of-Care, Decentralized CAR-T Manufacturing
9/13/2024
In this Cell & Gene Live segment, our panelists deliberate on the feasibility of decentralized, point-of-care CAR-T manufacturing and highlight the common concerns and challenges associated with POC manufacturing.
-
Vector Manufacturing
9/13/2024
In this segment, Cartesian Therapeutics SVP and head of manufacturing operations, Emily English, Ph.D., explains the company’s unique mRNA-based approach to CAR-T manufacturing.